Clinical Trial Update: A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001) [Phase 1]

View source ↗

Summary

This clinical trial update describes a Phase 1 study of KTX-2001 in metastatic castration-resistant prostate cancer (mCRPC) and notes that STRIKE-001 (NCT071030…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• KTX-2001

Snippet

Sponsor: K36 Therapeutics, Inc. | Conditions: Metastatic Castration-resistant Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer Patients | Phase 1 | Status: RECRUITING